Renal Metabolism of Glycolate to Oxalate

NARecruitingINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

March 12, 2020

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2026

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Low oxalate controlled Diet

Participants will consume a diet that is controlled in its contents of protein, carbohydrates, fat, calcium, oxalate, vitamin C and sodium. Participants will be asked not to take any dietary supplements, exercise strenuously, or consume food or drink that is not provided to them.

OTHER

Primed, continuous intravenous infusion of 13C2-Glycolate

Participants will receive a continuous intravenous administration of carbon-13 glycolate, a naturally occurring form of glycolate, over the course of several hours until steady-state is achieved, using an IV catheter.

OTHER

Bolus intravenous infusion of 13C2-Glycolate

Participants will receive a bolus intravenous administration of carbon-13 glycolate, a naturally occurring form of glycolate, using an IV catheter.

OTHER

Oral bolus administration of 13C2-Glycolate

Participants will orally ingest a single dose of carbon-13 glycolate, a naturally occurring form of glycolate.

Trial Locations (1)

35233

RECRUITING

University of Alabama at Birmingham, Birmingham

All Listed Sponsors
lead

University of Alabama at Birmingham

OTHER